BIOFBIOFOTC
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank69
Year-over-Year Change
Year-over-year research & development expense growth
Latest
3.01%
↓ 99% vs avg
Percentile
P69
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
230.13%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 3.01% |
| Q2 2025 | 34.43% |
| Q1 2025 | -65.62% |
| Q4 2024 | 148.29% |
| Q3 2024 | 40.98% |
| Q2 2024 | -52.05% |
| Q1 2024 | 459.26% |
| Q4 2023 | -63.00% |
| Q3 2023 | -61.50% |
| Q2 2023 | 11.42% |
| Q1 2023 | 144.99% |
| Q4 2022 | -30.86% |
| Q3 2022 | -7.41% |
| Q2 2022 | -64.52% |
| Q1 2022 | 242.99% |
| Q4 2021 | 55.99% |
| Q3 2021 | -7.95% |
| Q2 2021 | -5.77% |
| Q1 2021 | 190.52% |
| Q4 2020 | 2.31% |
| Q3 2020 | -81.88% |
| Q2 2020 | 443.08% |
| Q1 2020 | -58.53% |
| Q4 2019 | 0.00% |
| Q2 2018 | -28.66% |
| Q1 2018 | -84.68% |
| Q4 2017 | 0.00% |
| Q3 2017 | -100.00% |
| Q2 2017 | -58.35% |
| Q1 2017 | -71.38% |
| Q4 2016 | 8580.78% |
| Q3 2016 | -99.73% |
| Q2 2016 | -31.58% |
| Q1 2016 | 36.98% |
| Q4 2015 | -49.23% |
| Q3 2015 | -67.03% |
| Q2 2015 | 0.00% |
| Q1 2015 | 0.00% |
| Q4 2014 | -100.00% |
| Q3 2014 | 0.00% |